Susquehanna Fundamental Investments, LLC Hoth Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.85 - $3.04 $22,980 - $37,762	-12,422 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.58 - $2.37 $10,402 - $15,604	-6,584 Reduced 34.64%	12,422 $29,000
Q3 2020 Nov 16, 2020	BUY	$1.86 - $3.15 $7,265 - $12,303	3,906 Added 25.87%	19,006 $37,000
Q2 2020 Aug 14, 2020	BUY	$2.53 - $4.08 $38,203 - $61,608	15,100 New	15,100 $39,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.16M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.